Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment

被引:2
作者
Cardaba-Garcia, Maria E. [1 ,2 ]
Abad-Lecha, Encarnacion [2 ]
Calleja-Hernandez, Miguel A. [1 ,3 ]
机构
[1] Univ Granada, Campus Univ Cartuja, Fac Pharm, Granada, Spain
[2] Univ Valladolid, Hosp Pharm, Hosp Clin, Valladolid, Spain
[3] Virgen Macarena Univ Hosp, Hosp Pharm, Seville, Spain
关键词
hepatitis C virus; chronic hepatitis C; sustained virologic response; antiviral agents; predictive factors of response; SUSTAINED VIROLOGICAL RESPONSE; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; GENOTYPE; SOFOSBUVIR; INFECTION; SAFETY; EFFICACY; DACLATASVIR; CIRRHOSIS;
D O I
10.1080/19932820.2021.1949797
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims. Despite the high efficacy and safety of direct-acting antivirals against hepatitis C virus shown in clinical trials, treatment failures continue to occur. Our aim was to establish the effectiveness of these drugs in routine clinical practice, as well as to determine factors that could influence the response to the treatment.Matherials/methods. Single-center, observational, retrospective study. Clinical, virological and pharmacotherapeutic variables were registered at baseline. Adverse drug reactions that occurred were recorded until week 24 of follow-up. Achievement of sustained virologic response was also recorded. Univariate and multivariate analysis were done to determine factors of response.Results. A total of 333 treatment regimens corresponding to 330 different patients were evaluated. Sustained virologic response rate was 94.6% [95%CI: 91.6-96.6%]. 67.9% of the patients experienced adverse drugs reactions (92.2% were grade 1). The univariate analysis identified a higher baseline of platelets, albumin and total cholesterol as predictive factors of sustained virologic response (p < 0.05). Presence of diabetes and complications related to liver disease (splenomegaly, portal hypertension, portal hypertensive gastropathy), body mass index >= 30, greater liver fibrosis, receiving simeprevir and higher baseline levels of glucose, aspartate-aminotransferase, alanine-aminotransferase and alkaline-phosphatase, have been identified as predictive factors of non-response (p < 0.05). The multivariate analysis detected the following independent factors of non-response: body mass index >= 30 and presence of complications related to liver disease.Conclusion. The effectiveness and safety of direct-acting antivirals against hepatitis C virus have been maintained in routine clinical practice. Further research on predictive factors of response is required in order to develop more reliable and reproducible predictive models.
引用
收藏
页数:9
相关论文
共 38 条
[1]   Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection [J].
Afdhal, Nezam ;
Zeuzem, Stefan ;
Kwo, Paul ;
Chojkier, Mario ;
Gitlin, Norman ;
Puoti, Massimo ;
Romero-Gomez, Manuel ;
Zarski, Jean-Pierre ;
Agarwal, Kosh ;
Buggisch, Peter ;
Foster, Graham R. ;
Braeu, Norbert ;
Buti, Maria ;
Jacobson, Ira M. ;
Subramanian, G. Mani ;
Ding, Xiao ;
Mo, Hongmei ;
Yang, Jenny C. ;
Pang, Phillip S. ;
Symonds, William T. ;
McHutchison, John G. ;
Muir, Andrew J. ;
Mangia, Alessandra ;
Marcellin, Patrick .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (20) :1889-1898
[2]   Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels [J].
Akuta, Norio ;
Suzuki, Fumitaka ;
Kawamura, Yusuke ;
Yatsuji, Hiromi ;
Sezaki, Hitomi ;
Suzuki, Yoshiyuki ;
Hosaka, Tetsuya ;
Kobayashi, Masahiro ;
Kobayashi, Mariko ;
Arase, Yasuji ;
Ikeda, Kenji ;
Kumada, Hiromitsu .
JOURNAL OF HEPATOLOGY, 2007, 46 (03) :403-410
[3]   Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study [J].
Alam, Imtiaz ;
Brown, Kimberley ;
Donovan, Cynthia ;
Forlenza, Jamie ;
Lauwers, Kris ;
Mah'moud, Mitchell A. ;
Manch, Richard ;
Mohanty, Smruti R. ;
Prabhakar, Avinash ;
Reindollar, Robert ;
DeMasi, Ralph ;
Slim, Jihad ;
Tandon, Neeta ;
Villadiego, Shirley ;
Naggie, Susanna .
OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01)
[4]  
[Anonymous], 2014, Guidelines for the screening, care and treatment of persons with hepatitis C infection
[5]  
Asociacion Espanola para el Estudio del Higado . Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica, 2016, GUIAS AEEH SEIMC MAN GUIAS AEEH SEIMC MAN
[6]   Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial [J].
Asselah, Tarik ;
Hezode, Christophe ;
Qaqish, Roula B. ;
ElKhashab, Magdy ;
Hassanein, Tarek ;
Papatheodoridis, George ;
Feld, Jordan J. ;
Moreno, Christophe ;
Zeuzem, Stefan ;
Ferenci, Peter ;
Yu, Yao ;
Redman, Rebecca ;
Pilot-Matias, Tami ;
Mobashery, Niloufar .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (01) :25-35
[7]   Analysis of Host and Viral-Related Factors Associated to Direct Acting Antiviral Response in Hepatitis C Virus Patients [J].
Aziz, Hafsa ;
Aziz, Muneeba ;
Gill, Muzaffar Lateef .
VIRAL IMMUNOLOGY, 2018, 31 (03) :256-263
[8]   High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C [J].
Bressler, BL ;
Guindi, M ;
Tomlinson, G ;
Heathcote, J .
HEPATOLOGY, 2003, 38 (03) :639-644
[9]   Hepatitis C virus infection and the role of a pharmaceutical care program [J].
Chamorro-de-Vega, E. ;
Rodriguez-Gonzalez, C. G. ;
Gimenez-Manzorro, Alvaro ;
Herranz, A. ;
Sanjurjo, M. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (06) :479-486
[10]   Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study [J].
Colussi, GianLuca ;
Donnini, Debora ;
Brizzi, Rosario Francesco ;
Maier, Silvia ;
Valenti, Luca ;
Catena, Cristiana ;
Cavarape, Alessandro ;
Sechi, Leonardo Alberto ;
Soardo, Giorgio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (40) :6094-6106